T1	intervention 32 41	lidocaine
T2	duration 613 648	Between January 2006 and April 2009
T3	No-of-participants 650 653	140
T4	eligibility 654 687	patients with early breast cancer
T5	control 753 801	lidocaine cream and intradermal Tc-99m (control)
T6	intervention 898 925	sodium bicarbonate (NaHCO3)
T7	outcome 1165 1180	patient comfort
T8	outcome 1190 1213	SLN identification rate
T9	outcome 1237 1268	Technical aspects of SLN biopsy
T10	outcome 1441 1465	SLN identification rates
T11	control-value 1506 1510	96 %
T12	intervention-value 1524 1528	90 %
T13	intervention-value 1551 1555	97 %
T14	intervention-value 1592 1596	90 %
T15	outcome 1644 1675	SLN 2/SLN 1 ex vivo count ratio
T16	outcome 1685 1708	number of SLNs detected
